Lupin receives FDA approval for generic Solodyn tablets

Medicis’s Solodyn (Minocycline HCI, USP) Extended-release tablets had sales of $750 million as per IMS September 2011 data

Pharma major, Lupin Ltd, announced that its subsidiary, Lupin Pharmaceuticals Inc. has received final approval for its Minocycline hydrochloride extended-release tablets 45mg, 55mg, 90mg and 135mg strengths as well as tentative approval for its Minocycline HCl extended release tablets 65mg, 80mg, 105mg and 115mg strengths from the US Food and Drug Administration (FDA) for the company’s Abbreviated New Drug Application (ANDA) to market a generic version of Medicis Pharmaceutical Corporation’s (Medicis) Solodyn (Minocycline HCI, USP) extended-release tablets.

Solodyn is an oral antibiotic approved to treat only the red, pus-filled pimples of moderate to severe acne in patients 12 years of age and older. Medicis’s Solodyn (Minocycline HCI, USP) Extended-release tablets had sales of $750 million as per IMS September 2011 data.

In the late afternoon, Lupin was trading at around Rs469.35 per share on the Bombay Stock Exchange, 0.7% up from the previous close.

User

Tata Motors sales rise 41% in November

In the commercial vehicles segment, Tata Motors sold 44,737 units in the domestic market during the month under review compared to 35,079 units in the period last year, an increase of 27.53%

Tata Motors reported a 40.64% increase in its total vehicle sales during November, 2011, at 76,823 units. The company had sold 54,622 units in the same month last year.

The homegrown firm's total passenger vehicles sales in the domestic market stood at 27,737 units in November, up 80.81% from 15,340 units in the same month last year, Tata Motors said in a statement.

The company's small car Nano's sales stood at 6,401 units during the month compared to 509 units in the year-ago period, recording an over 12-fold jump.
The 'Indica' range reported a sales of 10,926 units against 5,716 units in the year-ago period, up 91.15%, Tata Motors said.

In addition, the 'Indigo' family recorded sales of 6,213 units, up 3.39 per cent in comparison to 6,009 units in the same month last year. Sales of 'Sumo', 'Safari' and 'Aria' grew by 35.13% to 4,197 units compared to 3,106 units in the corresponding period last year.

In the commercial vehicles segment, the company sold 44,737 units in the domestic market during the month under review compared to 35,079 units in the period last year, an increase of 27.53%.

Light commercial vehicle sales during the month amounted to 28,673 units, a growth of 40.72% over 20,376 units in the same month last year. The medium and heavy commercial vehicle sales stood at 16,046 units, a growth of 9.13% compared to 14,703 units in November 2010.

The company's exports increased by 3.47% to 4,349 units last month, from 4,203 units (in the same month last year), it added.

In the late afternoon, Tata Motors was trading at around Rs190.20 per share on the Bombay Stock Exchange, 3.99% up from the previous close.

User

Toyota Kirloskar sales jump over two fold in November

Toyota Kirloskar sold 3,943 units of the Etios and 4,328 units of the Liva last month

Car maker Toyota Kirloskar Motor reported an over two-fold increase in sales to 13,956 units in November, 2011, driven by robust demand for its latest 'Etios' and 'Liva' models.

The company had sold 5,242 units in the corresponding month last year, Toyota Kirloskar Motor (TKM) said in a statement. TKM, a joint venture between the world's largest car-maker Toyota and the Kirloskar Group, attributed the growth to healthy sales of its Etios sedan and small car Liva.

"We are very happy with the overwhelming response and confidence shown by our customers in the Etios and Etios Liva. The Etios series has sold a total of 8,271 units in November," TKM Deputy managing director (marketing) Sandeep Singh said.

The company sold 3,943 units of the Etios and 4,328 units of the Liva last month. It also sold 4,308 units of multi-utility vehicle Innova.

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)